Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
35.17 USD | -0.73% | -2.17% | -9.03% |
05-13 | Baxter International's Clinolipid Injection Approved for Expanded Use in US | MT |
05-10 | TD Cowen Downgrades Baxter International to Hold From Buy, Price Target is $40 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.03% | 17.92B | |
-4.72% | 182B | |
+3.96% | 114B | |
-2.93% | 68.38B | |
+6.30% | 52.46B | |
+8.02% | 44.25B | |
+7.52% | 43.55B | |
+26.18% | 32.69B | |
+17.85% | 26.73B | |
+0.57% | 25.79B |
- Stock Market
- Equities
- BAX Stock
- News Baxter International Inc.
- Transcript : Baxter International Inc., Q1 2024 Earnings Call, May 02, 2024